Booker S, Licht S, Broderick J, Stubbe J
Department of Chemistry and Biology, Massachusetts Institute of Technology, Cambridge 02139.
Biochemistry. 1994 Oct 25;33(42):12676-85. doi: 10.1021/bi00208a019.
Ribonucleoside triphosphate reductase (RTPR) from Lactobacillus leichmannii catalyzes the conversion of ribonucleotides to 2'-deoxyribonucleotides and requires adenosylcobalamin (AdoCbl) as a cofactor. Recent cloning, sequencing, and expression of this protein [Booker, S., & Stubbe, J. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 8352-8356] have now allowed its characterization by site-directed mutagenesis. The present study focuses on the role of five cysteines postulated to be required for catalysis. The choice of which of the ten cysteines of RTPR were to be mutated was based on extensive studies on the Escherichia coli ribonucleoside diphosphate reductase. Despite the differences between these two reductases in primary sequence, quaternary structure, and cofactor requirements, their mechanisms are strikingly similar. The mutagenesis studies reported herein further suggest that the complex role of the five cysteines is also very similar. A variety of single and double mutants of RTPR were prepared (C731S, C736S, C731 and 736S, C119S, C419S, C408S, and C305S), and their interaction with the normal substrate (CTP) was characterized under several sets of conditions. Mutants C731S, C736S, and C731 and 736S all catalyzed the formation of dCTP at rates similar to those of the wild-type (wt) enzyme in the presence of the artificial reductant DTT. In the presence of the in vivo reducing system (thioredoxin, thioredoxin reductase, and NADPH), however, each of these mutants catalyzed the formation of only 0.6-0.8 dCTPs per mole of enzyme. The inability of these mutants to catalyze multiple turnovers with respect to the in vivo reducing system suggests that their function might be to transfer reducing equivalents from thioredoxin into the active site disulfide of the reductase. Mutants C119S and C419S were targeted as being the active site cysteines, the ones which directly reduce the ribonucleotide substrate. As expected, neither of these mutants catalyzed the formation of dCTP. However, they did catalyze a time-dependent formation of cytosine, destruction of the cofactor, and the appearance of a chromophore associated with the protein--all phenotypes previously observed for the corresponding active site cysteines of the E. coli reductase. Mutant C408S was unable to catalyze dNTP production or cytosine release. Moreover, it was ineffective in catalyzing two additional reactions which are unique to this enzyme: the exchange of tritium from the 5' hydrogens of AdoCbl with H2O and the destruction of AdoCbl under anaerobic conditions to give 5'-deoxyadenosine and cob(II)alamin. These results are consistent with the role of this cysteine as the protein radical responsible for initiating catalysis.
来自莱氏乳杆菌的核糖核苷三磷酸还原酶(RTPR)催化核糖核苷酸转化为2'-脱氧核糖核苷酸,并且需要腺苷钴胺素(AdoCbl)作为辅因子。该蛋白最近的克隆、测序及表达研究[布克,S.,& 斯塔布,J.(1993年)《美国国家科学院院刊》90,8352 - 8356]现已使其能够通过定点诱变进行特性研究。本研究聚焦于推测催化过程所需的五个半胱氨酸的作用。RTPR的十个半胱氨酸中选择哪些进行突变是基于对大肠杆菌核糖核苷二磷酸还原酶的广泛研究。尽管这两种还原酶在一级序列、四级结构和辅因子需求方面存在差异,但它们的机制惊人地相似。本文报道的诱变研究进一步表明,这五个半胱氨酸的复杂作用也非常相似。制备了多种RTPR的单突变体和双突变体(C731S、C736S、C731和736S、C119S、C419S、C408S和C305S),并在几组条件下对它们与正常底物(CTP)的相互作用进行了表征。突变体C731S、C736S以及C731和736S在人工还原剂二硫苏糖醇(DTT)存在下,催化dCTP形成的速率与野生型(wt)酶相似。然而,在体内还原系统(硫氧还蛋白、硫氧还蛋白还原酶和NADPH)存在下,这些突变体每摩尔酶仅催化形成0.6 - 0.8个dCTP。这些突变体在体内还原系统中无法催化多次周转,这表明它们的功能可能是将还原当量从硫氧还蛋白转移到还原酶的活性位点二硫键中。突变体C119S和C419S被确定为活性位点半胱氨酸,即直接还原核糖核苷酸底物的半胱氨酸。正如预期的那样,这两种突变体都不催化dCTP的形成。然而,它们确实催化了胞嘧啶的时间依赖性形成、辅因子的破坏以及与该蛋白相关的发色团的出现——所有这些表型先前在大肠杆菌还原酶的相应活性位点半胱氨酸中都观察到过。突变体C408S无法催化dNTP的产生或胞嘧啶的释放。此外,它在催化该酶特有的另外两个反应时无效:AdoCbl的5'氢上的氚与H₂O的交换以及在厌氧条件下AdoCbl的破坏以生成5'-脱氧腺苷和钴胺(II)。这些结果与该半胱氨酸作为负责启动催化的蛋白自由基的作用一致。